Key stats
About iShares U.S. Pharmaceuticals ETF
Home page
Inception date
May 1, 2006
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
BlackRock Fund Advisors
Distributor
BlackRock Investments LLC
ISIN
US4642888360
IHE tracks a broad index of US pharmaceutical companies. The fund provides exposure to the manufacturers of prescription or over-the-counter drugs, such as aspirin, cold remedies and birth control pills. The index also includes vaccine producers. IHE may also include companies of all sizes, ranging from large- to small-cap. The index weights its constituents by market cap, with a cap of up to 22.5% per individual company and is rebalanced quarterly. IHE uses a sampling strategy that involves investing in a representative sample of securities that collectively has an investment profile similar to that of an applicable underlying index. Index components are selected on an annual basis.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.90%
Health Technology99.90%
Bonds, Cash & Other0.10%
Mutual fund0.10%
Cash0.00%
Stock breakdown by region
North America94.55%
Europe5.07%
Asia0.38%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
IHE top holdings are Johnson & Johnson and Eli Lilly and Company, occupying 24.30% and 19.91% of the portfolio correspondingly.
IHE last dividends amounted to 0.31 USD. The quarter before, the issuer paid 0.31 USD in dividends, which shows a 1.88% increase.
IHE assets under management is 570.77 M USD. It's fallen 1.99% over the last month.
IHE fund flows account for −82.19 M USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, IHE pays dividends to its holders with the dividend yield of 1.60%. The last dividend (Sep 19, 2025) amounted to 0.31 USD. The dividends are paid quarterly.
IHE shares are issued by BlackRock, Inc. under the brand iShares. The ETF was launched on May 1, 2006, and its management style is Passive.
IHE expense ratio is 0.38% meaning you'd have to pay 0.38% of your investment to help manage the fund.
IHE follows the DJ US Select / Pharmaceutical. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
IHE invests in stocks.
IHE price has fallen by −0.75% over the last month, and its yearly performance shows a −2.56% decrease. See more dynamics on IHE price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −0.56% over the last month, showed a 8.24% increase in three-month performance and has increased by 0.10% in a year.
NAV returns, another gauge of an ETF dynamics, have fallen by −0.56% over the last month, showed a 8.24% increase in three-month performance and has increased by 0.10% in a year.
IHE trades at a premium (0.04%) meaning the ETF is trading at a higher price than the calculated NAV.